干燥综合征肺部疾病评估与管理共识指南
该指南由干燥综合征基金会制定,遵循美国风湿病学会方法学,针对干燥综合征肺部表现提出52条推荐,涵盖气道疾病、间质性肺病和淋巴增殖性疾病的评估与管理,旨在提高早期识别和诊疗一致性。
要点
- 约16%干燥综合征患者存在肺部受累,死亡率更高且生活质量更低。
- 指南采用PICO格式提出85个临床问题,最终形成52条推荐。
- 推荐覆盖上/下气道疾病、间质性肺病和淋巴增殖性疾病的评估与管理。
核心结论
- 干燥综合征肺部表现临床实践指南可改善早期识别、评估和诊疗一致性。
研究设计与样本
- 指南由干燥综合征基金会制定,遵循美国风湿病学会方法学,由肺部专题审查组提出PICO临床问题并检索文献,经共识专家组审批,单条推荐需至少75%同意。
主要发现
- 文献检索共获得1192篇文章,其中150篇符合指南制定考虑标准。
- 专题审查组提出85个PICO问题,最终形成52条推荐。
- 52条推荐经共识专家组最终确定,平均同意率为97.71%(范围79%-100%)。
- 约16%的干燥综合征患者存在肺部受累,且死亡率更高、生活质量更低。
关键数值与推荐
- 单条推荐需至少75%同意方可纳入最终版本。
- 最终52条推荐平均同意率为97.71%(范围79%-100%)。
临床怎么用
- 指南供初级保健医生、风湿科医生和呼吸科医生用于干燥综合征患者肺部表现的早期识别、评估和诊疗。
- 推荐涵盖上、下气道疾病、间质性肺病和淋巴增殖性疾病的评估、管理与治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary disease is a potentially serious yet underdiagnosed complication of Sjögren's syndrome, the second most common autoimmune rheumatic disease. Approximately 16% of patients with Sjögren's demonstrate pulmonary involvement with higher mortality and lower quality of life. RESEARCH QUESTION: Clinical practice guidelines for pulmonary manifestations of Sjögren's were developed by the Sjögren's Foundation after identifying a critical need for early diagnosis and improved quality and consistency of care. STUDY DESIGN AND METHODS: A rigorous and transparent methodology was followed according to American College of Rheumatology guidelines. The Pulmonary Topic Review Group (TRG) developed clinical questions in the PICO (Patient, Intervention, Comparison, Outcome) format and selected literature search parameters. Each article was reviewed by a minimum of two TRG members for eligibility and assessment of quality of evidence and strength of recommendation. Guidelines were then drafted based on available evidence, expert opinion, and clinical importance. Draft recommendations with a clinical rationale and data extraction tables were submitted to a Consensus Expert Panel for consideration and approval, with at least 75% agreement required for individual recommendations to be included in the final version. RESULTS: The literature search revealed 1,192 articles, of which 150 qualified for consideration in guideline development. Of the original 85 PICO questions posed by the TRG, 52 recommendations were generated. These were then reviewed by the Consensus Expert Panel and 52 recommendations were finalized, with a mean agreement of 97.71% (range, 79%-100%). The recommendations span topics of evaluating Sjögren's patients for pulmonary manifestations and assessing, managing, and treating upper and lower airway disease, interstitial lung disease, and lymphoproliferative disease. INTERPRETATION: Clinical practice guidelines for pulmonary manifestations in Sjögren's will improve early identification, evaluation, and uniformity of care by primary care physicians, rheumatologists, and pulmonologists. Additionally, opportunities for future research are identified.
引用
- Lee AS, Scofield RH, Hammitt KM, et al. Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's. Chest. 2020. PMID: 33075377. doi:10.1016/j.chest.2020.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。